Acquisition Opportunity Curisium was acquired by HealthVerity in 2020, indicating a potential alignment with HealthVerity’s data exchange and privacy-focused capabilities. A sales approach could explore integration or continuation of Curisium’s blockchain-based contracting solutions within HealthVerity’s ecosystem or to expand HealthVerity’s customer reach.

Cloud Contracting The company specializes in cloud-based, data-driven contracting solutions for payers, pharmaceutical manufacturers, and providers. This positions Curisium to cross-sell expanded contract performance management, rebate processing, and data analytics services to mid-market healthcare payers and life sciences clients.

Early Stage Growth With a seed funding of $3.5M in 2017 and a lean team (11-50 employees), Curisium is likely seeking strategic partnerships to accelerate product development and go-to-market. Partnerships with health-tech integrators or venture-backed pharma tech firms could unlock larger deals.

Net Revenue Focus Reported revenue is under $1M, suggesting a high-value, transaction-heavy product with room to scale. Target customers that require scalable contracting platforms, such as small-to-mid sized pharma manufacturers and provider networks looking to streamline rebates and performance metrics.

Tech & Compliance The tech stack and blockchain-based contracting capability imply strengths in secure, auditable data processing. This can be highlighted in pitches to health plans and regulators seeking transparent, compliant contracting solutions and robust data governance.